Moreover, the use of inhibitors of lovastatin 3-hydroxy-3-methylglutaryl-coenzyme A, a rate-limiting step enzyme in cholesterol biosynthesis, reduced the expression of inflammatory factors Tnf and Icam-1 in T2DM mouse model (64). Here, TNF is linked to type 2 diabetes mellitus.